One limitation of the present study is that we examined only two papillary thyroid carcinoma derived cell lines and were unable to assess the effects of NKX2-1 overexpression in other thyroid cancer cells, such as PDTC or anaplastic thyroid carcinoma. The gene discussed is NKX2-1; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.